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Objective: to identify the degree of nicotine dependence among patients with schizophrenia 
and other mental disorders hospitalized in a general hospital, correlating these indices with 
clinical indicators and the meaning for the user. Method: the study was performed in the 
psychiatric unit of a general hospital, interviewing 270 patients with mental disorders using a 
questionnaire and the application of the Fagerstrom test. A descriptive statistical analysis of the 
data and thematic analysis of the content were performed. Results: among the 270 patients 
with mental disorders, 35.6% were smokers; of whom, 53.2% presented high or very high 
nicotine dependence. Of the 96 smokers, 32 (33.3%) were schizophrenic, among whom, 59.4% 
presented high or very high dependence. Higher levels of dependence were also found among 
the 59 elderly people (61.5%) and 60 subjects with somatic comorbidities (62.5%). Meanings 
of smoking for the subjects: helps to forget problems and face daily conflicts; alleviates side 
effects of the medications; self-control; distraction; part of life. Conclusion: more intense 
tobacco dependence among schizophrenic patients is justified due to it helping them to cope 
with the difficulties of the disease. Nurses occupy a strategic position in the care.
Descriptors: Smoking; Schizophrenia; Mental Health; Psychiatric Nursing.
Nicotine dependence in the mental disorders, relationship
with clinical indicators, and the meaning for the user1
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Introduction
Schizophrenia is a serious mental disorder that 
affects three out of every 10, 000 adults, of the global 
population. Despite the low incidence, the chronic course 
raises the prevalence to high levels, affecting 24 million 
people worldwide(1). 
Although delusions and hallucinations are the more 
recognized symptoms of schizophrenia in the clinical 
practice, negative symptoms and cognitive deficits are 
mostly responsible for the impairment of the social 
functioning of these individuals, with damage to work 
skills and social interaction(2-3). 
Epidemiological studies and meta analyzes 
agree that, in addition to psychosocial impairments, 
there are impairments of the physical health of 
individuals with schizophrenia (higher occurrence of 
cardiovascular and metabolic diseases and cancer) 
and decreased life expectancy. Tobacco use (eight in 
every 10) is one of the factors contributing to increased 
occurrences of crises, suicide attempts and need 
for hospitalization(4-7). 
The high prevalence of smoking among 
individuals with schizophrenia draws attention to 
a historical moment in which tobacco use is being 
discouraged by the government and by various social 
segments. 
Although psychiatric care has undergone 
intense transformations in recent decades, with the 
development of pharmacological therapy, constructing 
a healthcare network capable of receiving the 
deinstitutionalized individual, little progress has been 
made in relation to the smoking habits of patients with 
mental disorders. There are few national studies on 
tobacco use by patients with mental disorders and the 
factors associated with smoking.
The recognition of the seriousness of tobacco use 
for individuals with schizophrenia causes nursing to 
question what can be done to change this context, since 
in addition to deinstitutionalization, the patient with 
mental disorders needs to be given the conditions to 
have a better quality of life(5).
Nurses need to have technical and scientific 
knowledge about the effects of tobacco use among 
people with mental disorders, as this knowledge can be 
converted into care practices(8).
Therefore, this study aimed to answer the 
following questions: 1) What is the meaning of smoking 
for patients with mental disorders hospitalized in the 
psychiatric unit of a general hospital? 2) Which variables 
are associated with smoking in this population? 3) Is 
there a difference in the degree of nicotine dependence, 
clinical indicators and meanings of smoking among 
schizophrenic patients and the patients with other 
disorders?
Aims: to identify the degree of nicotine 
dependence among patients with schizophrenia and 
other mental disorders, hospitalized in the psychiatric 
unit of a general hospital, correlating these indices with 
the clinical indicators (diagnosis, duration of disease, 
therapies, psychiatric hospitalizations, and somatic 
comorbidities) and the meaning for the user. 
Method
This study used mixed convergent methods, 
answering the confirmatory and exploratory questions 
to the extent that the researchers could confirm 
their hypotheses through the hypothetical-deductive 
method (quantitative methodology) and generate new 
theories (induction) from the in-depth exploration 
of the phenomenon (qualitative methodology) and 
of the process by which the relationships between 
variables occur(9).
This study was conducted in the psychiatric ward 
of a university, state hospital complex, in the state of 
São Paulo. The institution is the reference for secondary 
and tertiary levels for an estimated population of 1, 
200, 000 inhabitants, living in 62 municipalities of 
the IX Regional Health Department (DRS IX). The 
psychiatric ward has 18 inpatient beds, with an mean 
occupancy of 15 patients per day and a mean hospital 
stay of 16 days.
A random probability sample was selected, 
which consisted of all the patients admitted to the 
psychiatric ward, from August 2010 to February 2012, 
with a mental and behavioral disorder diagnosis, and 
that agreed to participate in the study. Exclusion 
criteria: under 15 years of age; people diagnosed 
with mental retardation; users of alcohol and other 
drugs, without psychiatric comorbidities; people 
unable to communicate during the entire period of 
their hospitalization. 
The minimum of patients with mental disorders 
that smoked estimated for the sample was 96 subjects 
(maximum error of 10% and 95% accuracy). Considering 
that preliminary surveys in this unit estimated that 
approximately one third of all the patients were smokers, 
the total sample size (smokers, abstinent smokers and 
nonsmokers) was 270 subjects (Figure 1). 
687
www.eerp.usp.br/rlae
Oliveira RM, Siqueira Júnior AC, Santos JLF, Furegato ARF.
Figure 1 - Description of sampling procedure and statistical inference
Target population
People hospitalized in the
psychiatric ward of a
general hospital
Study population
All subjects hospitalized in the
psychiatric ward of the Clinical
Hospital of Marília
Sample
270 subjects hospitalized in this
ward between August 2010 and
February 2012
Individuals who used tobacco were considered 
smokers, regardless of the frequency of the use (daily 
and occasional smokers), the quantity used, and the 
length of time since beginning this practice, so as to 
cover both beginners and long-term smokers(10).
This study was approved by the Research Ethics 
Committee (EERP/USP 1173/2010, CAAE 2009. 
0.000.153-10). All the subjects signed the Terms of Free 
Prior Informed Consent.
Two instruments were used: 1) Smoker 
Identification Instrument for the Psychiatric Unit of 
a General Hospital (ITUP) and 2) Fagerstrom Test for 
Nicotine Dependence (FTND).
1) The ITUP is a questionnaire designed for 
this study, consisting of structured and semi-
structured questions for smokers, abstinent smokers 
and nonsmokers. The structured questions aim to 
identify characteristics of the subjects: personal and 
sociodemographic (gender, age, education, marital 
status, living arrangement, origin, occupation, and 
income), clinical indicators (diagnosis, therapy received, 
psychiatric hospitalizations, and somatic comorbidities), 
and daily living habits (alcohol, coffee, illicit substances, 
games, television, physical exercise, reading, cultural 
activities, going out and traveling). Only the smokers 
responded to the semi-structured questions: duration of 
smoking; age at which smoking began; daily amount 
of cigarettes; monthly expenditure; attempts to quit 
smoking; whether the person feels able to quit smoking; 
effects of tobacco on the body and on the behavior; 
whether the person considers him/herself a smoker, and 
the meaning of tobacco in his/her life.
2) Fagerstrom Test for Nicotine Dependence 
(FTND), composed of six questions that classify the 
degree of dependency as very low, low, moderate, high, 
and very high. Validated in Brazil in 2002 (test-retest 0. 
915 and Cronbach’s α 0. 642)(11). 
A total of 270 patients with mental disorders were 
interviewed and their responses were recorded using the 
form. The responses to the semi-structured questions 
were recorded and transcribed.
The statistical analysis of the quantitative data 
was performed using the Stata program (version 
10. 10), with the application of tools of descriptive 
statistics and bivariate analysis (Fisher’s exact test or 
chi-square test, with maximum probability of error – 
alpha of 5%).
The qualitative data (content expressed by the 
subjects) underwent thematic analysis to identify 
the effect of tobacco use for the patients with mental 
disorders. Frequencies were calculated for the different 
meanings identified. 
In convergent mixed methods, the quantitative 
and qualitative data were analyzed independently, 
however, with the triangulation of the information in the 
discussion(9).
Results
Characterization of the personal, sociodemographic 
data and clinical indicators of the subjects 
Of the 270 patients with mental disorders of this 
study, 91 (70.7%) were women. The participants 
had a mean age of 38.9 years (15-88); 235 (87%) 
had completed elementary or high school education, 
and 35 (13%) higher education; 108 (40%) were 
single, 105 (38.9%) married, 37 (13.7%) separated 
or divorced, and 20 (7.4%) widowed; 126 (46.7%) 
were living without a partner, but with family; 184 
resided in the city under study; 176 (65.2%) had some 
type of occupation; and the median family income 
was R$ 1,000.00.
Of the subjects studied, 226 (83.7%) had 
schizophrenia, mood and personality disorders; 62 
(23%) subjects had not been receiving psychiatric 
monitoring, prior to the current hospitalization, 128 
(47.4%) had received medication only, and 80 (29.6%) 
had received medication in association with other 
interventions (psychological counseling, support groups, 
occupational therapy). A total of 136 patients (50.7%) 
were hospitalized for the first time.
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Characterization of the activities and habits of daily 
life of the subjects 
Among the 270 patients with mental disorders 
of the study, 96 (35.6%) reported using tobacco. The 
length of time from the start of smoking until that 
moment, ranged from 3 days to 52 years. Of the 96 
smokers, 50 (52.1%) began smoking between 11 and 
15 years of age. At that time, they smoked a mean of 
24.2 cigarettes per day (1-100 cigarettes) [standard 
deviation (s=19 cigarettes/day)] and spent a mean of 
R$ 86.00 per month on tobacco.
Table 1 presents the frequency of the activities 
and habits of daily life, reported by the 270 patients 
with mental disorders. It can be seen that activities 
and habits considered healthy, such as physical 
exercise, reading, cultural activities and traveling, had a 
low frequency. 
Table 1 - Activities and habits of daily life of the 270 
patients with mental disorders. Marilia, SP, Brazil, 2012
Table 2 - Variables associated with the level of nicotine dependence of the 96 patients with mental disorders. Marilia, 
SP, Brazil, 2012
Table 1 - (continuation)
Activities and habits of daily life n %
Television 215 79.6
Coffee 200 74.1
Going out 143 53
Reading 130 48.2
Physical exercise 79 29.3
Traveling 75 27.8
Alcohol 44 16.3
Cultural activities 40 14.8
Variables associated
with smoking














1-10 11(78.6) 7(38.9) 4(30.8) 1(3.6) 1(4.4) 24(25.0)*
More than 11 3(21.4) 11(61.1) 9(69.2) 27(96.4) 22(95.7) 72(75.0)
Smoking duration
≤20 years 11(78.6) 9(50.0) 7(53.9) 14(50.0) 5(21.7) 46(47.9)†
≥21 years 3(21.4) 9(50.0) 6(46.2) 14(50.0) 18(78.3) 50(50.1)
Monthly spending
None 3(21.4) 3(3.1)‡
≤R$60 9(64.3) 15(83.3) 10(76.9) 16(57.1) 2(8.7) 52(54.2)
>R$60 2(14.3) 3(16.7) 3(23.1) 12(42.9) 21(91.3) 41(42.7)
Able to quit
Yes 14(100) 12(66.7) 7(53.9) 12(42.7) 9(39.1) 54(56.3)§
Tried to quit
Yes 8(57.1) 17(94.4) 12(92.3) 21(75.0) 23(100) 81(84.4)§
(continue...)
(continue...)
Degree of nicotine dependence and its association 
with the variables studied 
The Fagerstrom Test for Nicotine Dependence 
(FTND) was applied with the 96 patients with mental 
disorders that reported using tobacco. Fifty-one subjects 
(53.2%) were classified as having a high or very high 
level of dependence, 13 (13.5%) a moderate level, 18 
(18.8%) a low level, and 14 (14.6%) with a very low 
level of nicotine dependence.
Of the 96 smokers, 32 (33.3%) were schizophrenic, 
among whom 59.4% (χ2=39.0037, Pr=0.027) had a 
high or very high level of dependence.
Higher levels of nicotine dependence (high 
and very high) were also found among the elderly 
patients (61.9%, Fisher 0.006) and those with somatic 
comorbidities – cardiovascular, digestive, endocrine, 
respiratory (62%, Fisher 0.048).
Furthermore, it was found that the smokers more 
regularly used alcohol (Fisher 0.006), illicit substances 
(Fisher 0.001) and coffee (Fisher 0.000), with no 
evidence of an association between the level of nicotine 
dependence and these variables (Fisher’s exact test: 
alcohol 0.837; illicit substances 0.523; coffee 0.380). 
Some variables associated with the level of nicotine 
dependence are presented in Table 2.
Activities and habits of daily life n %
Games 21 7.8
Illicit substances 13 4.8
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*Fisher test – significant result: *0.000
†Fisher test – significant result: †0.016
‡Fisher test – significant result: 0.000
§Fisher test – significant result: 0.002
|| Fisher test – significant result: 0.037
¶Fisher test – significant result: 0.026
**Fisher test – significant result: 0.001
Table 2 - (continuation)
Variables associated
with smoking













Effects on the body
Yes 12(85.7) 18(100) 13(100) 28(100) 23(100) 94(97.9)||
Effects on the behavior
Yes 12(85.7) 18(100) 12(92.3) 28(100) 23(100) 93(96.9)¶
Considers oneself a smoker 5(35.7) 14(77.8) 9(69.2) 25(89.3) 21(91.3) 74(77.1)**
Total 14(100) 18(100) 13(100) 28(100) 23(100) 96(100)
The meaning of tobacco use for the smokers (S) with 
mental disorders 
The majority of the smokers believed that tobacco 
use among psychiatric patients is different from that 
of other people: 75 (78.1%) believed that psychiatric 
patients smoke more cigarettes than the general 
population and 69 (71.9%) believed that the psychiatric 
population find it more difficult to quit. 
There was higher proportion of subjects among the 
schizophrenic patients, 30 (93.8%), who believed that 
psychiatric patients smoke more cigarettes than other 
people (Fisher 0.036), a higher proportion in relation 
to each of the other disorders, as well as compared 
to the total sample of smokers. The greater difficulty 
to quit smoking was also positively associated with a 
higher frequency of previous psychiatric hospitalizations 
(Fisher 0.042).
In the statements of the 96 smokers with 
mental disorders, three categories were identified, 
related to the meanings attributed to tobacco 
use by the psychiatric patients: The cigarette is a 
support to face the difficulties originating from the 
mental disorder; Smoking alleviates the psychiatric 
symptoms and side effects of the medication; Smoking 
gives pleasure. 
Category 1 – The cigarette is a support to face difficulties 
originating from the mental disorder
Tobacco, according to 31.3% of the psychiatric 
patients, serves as support to forget the everyday 
problems and, according to 3.1%, to cope with the 
stigma.
Smoking is an escape valve. We need to take refuge in 
something. (S95)
The most difficult thing is the discrimination of the people. 
I’m afraid to go outside, but I face it with the cigarette. (S66)
Some subjects (5.2%) considered tobacco 
irreplaceable and necessary for life.
I have still not found anything that can replace the 
cigarette. (S28)
Somehow, it [the cigarette] supplies something here. (S72)
For those patients without motivation to continue 
living, tobacco is seen as a form of self-destruction 
(6.3%).
I have no more will to live, so for me it does not 
matter. (S50)
Category 2 – Smoking alleviates the psychiatric 
symptoms and side effects of the medication 
The majority of the smokers (78.1%) used tobacco 
to self-medicate the psychiatric symptoms. Some 
(5.2%) reported that cigarette smoking increases self-
control and decreases impulsivity.
The cigarette, for me, the way I’m depressed, it became a 
kind of medicine. (S61)
Cigarettes help decrease impulsivity. (S29)
A total of 79% of the smokers believed that smoking 
reduces anxiety, 57.3% that it improves the mood, and 
29.2% and that improves concentration.
Tobacco was also used to alleviate the side effects 
of the psychiatric medications (4.2%).
The drugs make me a little sleepy, so I’ll go and 
smoke. (S14)
Category 3 – Smoking gives pleasure
Tobacco was used for pleasure (28.1%) and as a 
distraction to pass the time (18.8%). 
Just the pleasure of smoking is enough not to quit. The 
cigarette gives me pleasure that I don’t find in other things. (S28)
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When I have nothing to do I smoke. It’s a way to pass the 
time. (S66)
Some participants recognized the cigarette as 
a companion in times of loneliness (14.6%) and as a 
facilitator of social interactions (6.3%).
The cigarette is a friend, a companion. Even when I’m 
alone it is my companion. It cannot talk, but it is always there 
with me. (S70)
When we smoke it seems like the conversation flows. It 
seems like you have the strength to continue talking, to be freer, 
more secure. (S46)
Frequency of the meanings attributed to tobacco 
use by the schizophrenic patients: helps you to forget 
problems (46.7%); alleviates the side effects of the 
psychiatric medications (50%); self-control (60%); 
distraction to pass the time (44.4%); coping with stigma 
(66.7%); irreplaceable/necessary for life (80%). 
In the statements of the patients with mood 
disorders, the more frequent meanings of tobacco use 
were: self-destruction (50%); a companion in times of 
loneliness (42.9%); a facilitator of social interactions 
(66.7%); pleasure (40.7%); and irreplaceable/
necessary for life (50%). The schizophrenic patients 
and those with personality disorders also presented high 
frequencies in these aspects. 
The patients with mental disorders and a high or 
very high level of nicotine dependence were those that 
most reported tobacco use as an aid to forget problems 
(53.4%), self-destruction (66.6%), a companion in 
times of loneliness (57.1%), a facilitator of social 
interactions (66.6%) and as irreplaceable and necessary 
for life (80%).
Discussion
This study supports the hypothesis that tobacco 
use is more common among individuals with mental 
disorders (by approximately one third) than in the 
other groups of the population, given that the current 
prevalence of smoking in the Brazilian population is 
17.5%(12). 
Studies conducted in Australia, United States 
and Israel show that the frequency of smoking among 
patients with mental disorders is approximately twice 
that found in people with no history of psychiatric 
illness(13-15).
Although one third of the subjects in this study 
were smokers, this information was not registered 
in any patient records, despite nicotine dependence 
being a diagnosis recognized by the ICD 10 or DSM IV. 
Studies in the United States and Switzerland, also on 
the absence of smoking registration in patient records, 
suggest that professionals do not worry about tobacco 
use in psychiatric hospitalization(13,16). 
In this study, an association was found between the 
use of tobacco, illicit substances and alcohol. A study with 
745 schizophrenic patients hospitalized in psychiatric 
services of the state of Maryland, United States, found 
that those who were using large amounts of cigarettes 
per day were more likely to use alcohol and illicit 
substances. The association between tobacco and these 
substances is worrying because it increases the risk of 
the psychiatric patient developing somatic complications 
(cardiac, respiratory, hepatic, gastrointestinal and 
neurological), as well as changes in the behavior and 
sleep pattern(17).
The results of the present study showed that 
tobacco dependence is more intense among individuals 
with schizophrenia, confirming the results of a meta-
analysis performed with studies from 20 countries. 
The meta-analysis also revealed that lower rates of 
the discontinuation of tobacco use are found among 
schizophrenic patients(4). Recent studies conducted in 
the United States, Israel and Brazil also showed high 
levels of nicotine dependence among individuals with 
schizophrenia(17-19).
The high level of nicotine dependence among 
subjects with somatic comorbidities is consistent with 
the knowledge that smoking is a risk factor for physical 
complications. A Brazilian study, with 100 patients 
who suffered acute myocardial infarction, showed that 
the smokers had a greater perception of the risk of 
becoming ill, as they sought professional help faster 
than the other subjects when faced with the myocardial 
infarction symptoms(20).
The subjects with higher nicotine dependence, 
in the present study, felt less able to quit smoking. A 
study of 200 psychiatric patients in the United States 
revealed that the individuals with schizophrenia and 
schizoaffective disorder felt less motivated to quit 
smoking than the other subjects(21). 
An Australian study revealed that the patients 
with psychotic disorders used tobacco to confront 
the challenges originating from the mental disorder 
and the pharmacological therapy – relief from the 
collateral effects of the medications, reduction of the 
symptoms, and for pleasure and relaxation(22). Although 
the psychiatric patients with more severe tobacco 
dependence are the ones who perceive the effects of 
smoking on their bodies and behavior, they are also the 
ones with a higher frequency of failed attempts to quit. 
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In some of the patient records of the subjects of this 
study, there were records reminding the nursing team to 
warn smokers about the times that smoking is allowed. 
This is recognition of the participation of nursing in the 
culture of smoking in psychiatric hospitalizations. 
The continuous care provided by the nursing team, 
in the inpatient psychiatric units, allows them to become 
closer to the patients. Nursing actions, aimed at reducing 
smoking and promoting a healthier lifestyle among 
patients with mental disorders should be a priority.
An Australian study recommends that psychiatric 
patients should be given assistance to find resources that 
help them cope with the mental disorder. Interventions 
for the abandonment of substance use, including 
tobacco, may have more success when included in the 
therapeutic plan(22-23). 
Nurses are key players in the multidisciplinary 
team, as they accompany the patients and know their 
behavior well, which can be used to help the patients 
become aware of the resources they have to cope with 
the disorder and the tobacco use. For this, nurses need 
to be prepared and willing to collaborate.
Conclusions
A higher level of nicotine dependence was 
associated with older age, the diagnosis of schizophrenia, 
and the presence of somatic comorbidities. Both the 
schizophrenic patients and the subjects with higher levels 
of dependence used tobacco to cope with the difficulties 
arising from the mental disorder – they reported that 
tobacco helps them to forget their problems and to 
confront everyday conflicts, provides relief from the side 
effects of the medication, and helps with self-control. 
They also consider tobacco to be part of their lives. 
Tobacco use by schizophrenic patients is a 
challenge for psychiatry. Nurses are in a strategic 
position to intervene in this context, with preventive 
and rehabilitative actions in the therapeutic plan of each 
patient under their care.
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